澳门老奇人论坛

Meeting Coverage >

HFSA

SGLT2 Inhibitor Eases Symptoms for HFpEF Patients

Trial suggests hard outcomes not the only ones helped by this class of medication

Second-Gen Drug for HCM Emerges, Nipping at Mavacamten's Heels

Novel cardiac myosin inhibitor is headed for a phase III trial

Heart Failure's 'Golden Moment' Not Translating into Better Health

Problems of implementation and health equity persist

Feared ARNI Effect on Cognition Hasn't Come to Fruition

Neurocognitive protection by sacubitril/valsartan suggested instead by observational study

Virtual Heart Failure Care No Substitute for the Face-to-Face Visit?

Reduced GDMT titration suggests a dip in quality of care

Phrenic Nerve Stimulation Holds Up for Central Sleep Apnea

Apnea indices, daytime sleepiness improved over 5 years

Translational Research: Diet Affects the Heart in Multiple Ways

Inflammation, circadian rhythm, and beyond

Shared Decision-Making: Cardiologists Moving Through the Stages of Grief

Rules from CMS for ICDs, LAA closure feels arbitrary, some say

Study: LVAD Surgical Technique Can be Further Refined

Left ventricular assist device outflow cannula angulation, anastomosis size may be important

Debate: Is LVEF Really that Important in Heart Failure?

Benefit of identifying preserved, reduced, mid-range, supranormal EF under question

Drop in Long-Term Stroke Complications with Newer LVAD

Data show even "mild" strokes are far from benign, though

For HFpEF, Better Heart-Lung Connection with Albuterol

Beta-agonist associated with improved exercise hemodynamic measures

HF Monitor Trips on PA Injury in Postmarket Surveillance

Reintervention or device recalibration often needed after PA injury

HFSA: Clinical Benefits Tied To Lung Monitoring Persist

HF rehospitalization, deaths remain reduced up to 4.5 years

Cardiac Myosin Activator Shows Promise for LV Function

'More hands pulling on the rope'

HFSA: Treat to NT-proBNP Target Flops in Trial

Outcomes no better with treatment aimed at 30% reduction

HFSA: Did LAP Monitoring Cut HF Rehospitalizations?

LAPTOP-HF investigators tried to make sense of terminated study

HFSA: Controversy Highlighted at Upcoming Meeting

BOSTON -- Much progress has been made in managing heart failure, but there are still some areas of controversy that will be highlighted at the upcoming meeting of the Heart Failure Society of America here.